April 13, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Top 15 specialty pharmacies by 2022 revenue Full story 2. This pharma company hasn't licensed a single drug in 15 years, made $3B in 2022 Full story 3. 2 gene therapies…
Pharmacy Report
April 12, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Fentanyl-xylazine mix labeled an 'emerging threat' Full story 2. Lawmakers call for FDA to ignore Texas abortion pill ruling Full story 3. Biogen reduces multiple sclerosis team Full story 4. When it comes…
April 11, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 10 exclusives Mark Cuban told Becker's in April Full story 2. Another cancer drug is backordered Full story 3. Ripples from the Texas abortion case: 4 updates Full story 4. Solving OR inefficiencies…
April 10, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 5 states broaden reimbursement for pharmacists Full story 2. Abortion pill rulings: What happens next Full story 3. As drug shortages swell, FDA seeks more clarity from manufacturers Full story 4. When it…
April 6, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA pulls approval of only preterm birth drug Full story 2. California can't be 'done' with Walgreens, legal experts say Full story 3. Are physicians ready to deploy future therapies? Full story…
April 5, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA authorizes new COVID-19 drug Full story 2. Cuban's pharmacy picks up J&J brand-name drugs Full story 3. Lawmakers take aim at PBMs, 'spread pricing' Full story 4. Are your claims actually getting…
April 4, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA stops cancer drug trial after two patient deaths Full story 2. New York launches Medicaid pharmacy benefit program Full story 3. Ozempic's No. 1 competitor could upend its success Full story…
April 3, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 5 weeks later, Akorn's closure racks up 13 swelling drug shortages Full story 2. 15 best pharmacy schools for first-time NAPLEX pass rates Full story 3. Burnout is increasing among pharmacy…
March 30, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. How an alleged monkey smuggling scheme can stifle drug research Full story 2. Arizona nixes physician prescription requirement for birth control Full story 3. Canadian province slows Ozempic sales to US:…
March 29, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Rural hospitals could soon have a harder time stocking drugs Full story 2. Walgreens won't increase wages for some workers, CEO says Full story 3. Evergreen Health sues New York over…